Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Technology
Vandana Singh

Editas Suddenly Terminates Chief Medical Officer Without An Explanation

Editas Medicine Inc (NASDAQ:EDIT) has fired Chief Medical Officer Lisa Michaels just 15 months into her tenure at the Company.

  • The biotech was mum on the reasoning for the termination, disclosed in a Securities and Exchange Commission filing
  • The termination that occurred today is effective immediately.
  • According to the SEC filing, Michaels will receive her base salary for another 12 months. 
  • Related: Here's Why Editas Stock Dropped After Data From CRISPR-Based Retinal Disorder Candidate.
  • RBC Capital Markets analyst called the news "incrementally negative" and wrote in a note that the firing "does not boost confidence" in a company with mixed clinical signals for LCA10 and high management turnover. 
  • Analyst Luca Issi remains on the sidelines with a Sector Perform rating and $40 price target on Editas shares given what he views as mixed data for its lead asset, a "crowded" SCD space, and an oncology pipeline that remains early.
  • Price Action: EDIT shares are down 7.40% at $17.89 during the market session on the last check Tuesday.
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.